Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin

Cornea

Volumn 25, Issue 6, 2006, Pages 709-714

  Djalilian, Ali R ^a,b   Nagineni, Chandrasekharam N ^a   Mahesh, Sankanaranayana P ^a   Smith, Janine A ^a   Nussenblatt, Robert B ^a   Hooks, John J ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemokines; Cornea; Cyclosporin; Cytokines; Dexamethasone; Inflammation

Indexed keywords

CHEMOKINE; CYCLOSPORIN; CYTOKINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ARTICLE; CONTROLLED STUDY; CORNEA CELL; CORNEA STROMA; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN SECRETION;

ANTI-INFLAMMATORY AGENTS; CELL CULTURE TECHNIQUES; CHEMOKINE CCL2; CORNEAL STROMA; CYCLOSPORINE; CYTOKINES; DEXAMETHASONE; EPITHELIUM, CORNEAL; FIBROBLASTS; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MONOCYTE CHEMOATTRACTANT PROTEINS; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33750555388     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000208815.02120.90     Document Type: Article

References (33)

1. Foster CS. Immunologic disorders of the conjunctiva, cornea, and sclera. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, Vol. 2. 2nd ed. Philadelphia, PA: WB Saunders; 2000:803-828.
2. Dana MR, Qian Y, Hamrah P. Twenty-five year panorama of corneal immunology. Cornea. 2000;19:625-643.
3. Cubitt CL, Tang Q, Monteiro CA, et al. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci. 1993;34:3199-3206.
4. Cubitt CL, Lausch RN, Oakes JE. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and fibroblasts. Invest Ophthalmol Vis Sci. 1995;36:330-336.
5. Cubitt CL, Lausch RN, Oakes JE. Differential regulation of granulocyte-macrophage colony stimulating factor gene expression in human corneal cells by pro-inflammatory cytokines. J Immunol. 1994;153:232-240.
6. Tran MT, Tellaetxe-Isusi M, Elner V, et al. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. Beta-chemokine synthesis in corneal cells. Invest Ophthalmol Vis Sci. 1996;37:987-996.
7. Xue ML, Zhu H, Willcox M, et al. The role of IL-1beta in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization. Curr Eye Res. 2001;23:406-414.
8. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997;63:1501-1507.
9. Daun JM, Fenton MJ. Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. J Interferon Cytokine Res. 2000;20:843-855.
10. Wilson SE, Schultz GS, Chegini N, et al. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-71.
11. Yamada J, Dana MR, Sotozono C, et al. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res. 2003;76:161-167.
12. Leibowitz HM, Kupferman A. Antiinflammatory medications. Int Ophthalmol Clin. 1980;20:117-134.
13. De Bosscher K, Vanden Berghe W, Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol. 2000;109:16-22.
14. Kahan BD. Cyclosporine: the agent and its actions. Transplant Proc. 1985;17:5-18.
15. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
16. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characteristics. Invest Ophthalmol Vis Sci. 1995;36:614-621.
17. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445.
18. Keadle TL, Usui N, Laycock KA, et al. IL-1, TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 2000;41:96-102.
19. Hazlett LD. Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines. DNA Cell Biol. 2002;21:383-390.
20. Spandau UH, Toksoy A, Verhaart S, et al. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol. 2003;121:825-831.
21. Yamagami S, Miyazaki D, Ono SJ, et al. Differential chemokine gene expression after corneal transplantation. Invest Ophthalmol Vis Sci. 1999;40:2892-2897.
22. Barraquer J. Immunosuppressive agents in penetrating keratoplasty. Am J Ophthalmol. 1985;100:61-64.
23. Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea. 1993;12:413-419.
24. Hill JC. Systemic cyclosporine in high risk keratoplasty: long term results. Eye. 1995;9:422-428.
25. Zhao JC, Jin XY. Local therapy of corneal allograft rejection with cyclosporine. Am J Ophthalmol. 1995;119:189-194.
26. Halloran PF, Kung L, Noujaim J. Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc. 1998;30:2167-2170.
27. Baudouin C, Brignole FP, Pisella PJ, et al. Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporine A. Adv Exp Med Biol. 2002;506:761-769.
28. Seitz DP, Pasha MK, Singh B, et al. Localization and characterization of calcineurin in bovine eye. Invest Ophthalmol Vis Sci. 2002;43:15-21.
29. Acheampong AA, Shackleton M, Tang-Liu DD, et al. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr Eye Res. 1999;18:91-103.
30. Wiederholt M, Kossendrup D, Schulz W, et al. Pharmacokinetic of topical cyclosporin A in the rabbit eye. Invest Ophthalmol Vis Sci. 1986;27:519-524.
31. Fukagawa K, Saito H, Tsubota K, et al. RANTES production in a conjunctival epithelial cell line. Cornea. 1997;16:564-570.
32. Leonardi A, DeFranchis G, Fregona IA, et al. Effects of cyclosporin A on human conjunctival fibroblasts. Arch Ophthalmol. 2001;119:1512-1517.
33. West-Mays JA, Cook JR, Sadow PM, et al. Differential inhibition of collagenase and interleukin-1alpha gene expression in cultured corneal fibroblasts by TGF-beta, dexamethasone, and retinoic acid. Invest Ophthalmol Vis Sci. 1999;40:887-896.